Company logo

BIOL - BIOLASE, Inc.

NASDAQ -> Healthcare -> Medical Devices
Foothill Ranch, United States
Type: Equity

BIOL price evolution
BIOL
(in millions $) 1 May 2023 31 Jan 2023 30 Sep 2022 30 Jun 2022
Current assets
Cash $6.53 $4.18 $9.96 $19.55
Short term investments
Net receivables $5.16 $5.84 $4.85 $6.08
Inventory $17.77 $15.88 $16.43 $16.57
Total current assets $31.96 $28.96 $33.88 $44.27
Long term investments
Property, plant & equipment $6.8 $6.05 $5.82 $3.42
Goodwill & intangible assets $2.93 $2.93 $2.93 $2.93
Total noncurrent assets $9.98 $9.23 $8.98 $6.59
Total investments
Total assets $41.94 $38.19 $42.87 $50.85
Current liabilities
Accounts payable $7.54 $5.79 $4.97 $4.96
Deferred revenue $2.44 $2.53 $2.22 $2.82
Short long term debt $1.4 $0.7
Total current liabilities $19 $17.81 $13.76 $13.95
Long term debt $13.93 $13.09 $14.22 $14.32
Total noncurrent liabilities $14.79 $15.49 $15.24 $15.29
Total debt $15.33 $15.05 $14.22 $14.32
Total liabilities $33.79 $33.3 $29.01 $29.24
Shareholders' equity
Retained earnings -$302.02 -$296.17 -$286.31 -$277.92
Other shareholder equity -$0.65 -$0.73 -$1.04 -$0.89
Total shareholder equity $8.16 $4.89 $13.86 $21.61
(in millions $) 31 Jan 2023 31 Dec 2021 31 Dec 2020 31 Dec 2019
Current assets
Cash $4.18 $30.18 $17.88 $6.1
Short term investments
Net receivables $5.84 $4.24 $3.06 $8.76
Inventory $15.88 $12.93 $11.16 $10.99
Total current assets $28.96 $49.35 $35.11 $27.02
Long term investments
Property, plant & equipment $6.05 $2.78 $2.76 $1.47
Goodwill & intangible assets $2.93 $2.93 $2.93 $2.93
Total noncurrent assets $9.23 $5.93 $5.92 $4.83
Total investments
Total assets $38.19 $55.28 $41.02 $31.85
Current liabilities
Accounts payable $5.79 $3.31 $2.65 $5.33
Deferred revenue $2.53 $2.59 $2.28 $2.6
Short long term debt $0.7 $13.47
Total current liabilities $17.81 $13.84 $11.22 $25.78
Long term debt $13.09 $15.05 $17.96
Total noncurrent liabilities $15.49 $16.23 $19.77 $1.73
Total debt $15.05 $15.05 $17.96 $13.47
Total liabilities $33.3 $30.08 $31 $27.5
Shareholders' equity
Retained earnings -$296.17 -$267.53 -$251.38 -$234.55
Other shareholder equity -$0.73 -$0.62 -$0.39 -$0.7
Total shareholder equity $4.89 $25.21 $10.03 $0.38
(in millions $) 1 May 2023 31 Dec 2022 30 Sep 2022 30 Jun 2022
Revenue
Total revenue $14.05 $12.01 $12.23
Cost of revenue $10.46 $9.56 $7.09
Gross Profit $3.6 $2.44 $5.14
Operating activities
Research & development $2.09 $1.98 $1.65
Selling, general & administrative $9.94 $8.12 $8.54
Total operating expenses $12.02 $10.1 $10.2
Operating income -$8.43 -$7.65 -$5.05
Income from continuing operations
EBIT -$8.31 -$7.98 -$5.16
Income tax expense $0.09 -$0.02 $0.02
Interest expense $1.46 $0.42 $0.43
Net income
Net income -$9.86 -$8.39 -$5.61
Income (for common shares) -$9.86 -$8.39 -$5.61
(in millions $) 31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Revenue
Total revenue $48.46 $39.19 $22.78 $37.8
Cost of revenue $32.55 $22.66 $16.61 $23.51
Gross Profit $15.91 $16.53 $6.17 $14.29
Operating activities
Research & development $7.26 $6.05 $3.69 $4.76
Selling, general & administrative $33.98 $26.6 $21.01 $25.14
Total operating expenses $41.25 $32.96 $24.71 $29.91
Operating income -$25.34 -$16.43 -$18.54 -$15.62
Income from continuing operations
EBIT -$25.78 -$13.87 -$14.34 -$15.74
Income tax expense $0.11 $0.07 $0.13 -$0.04
Interest expense $2.75 $2.22 $2.36 $2.16
Net income
Net income -$28.63 -$16.16 -$16.83 -$17.86
Income (for common shares) -$28.85 -$16.16 -$16.83 -$17.86
(in millions $) 31 Mar 2023 31 Dec 2022 30 Sep 2022 30 Jun 2022
Net income -$5.85 -$9.86 -$8.39 -$5.61
Operating activities
Depreciation $0.15 $0.13 $0.12 $0.13
Business acquisitions & disposals
Stock-based compensation $0.69 $0.72 $0.59 $0.89
Total cash flows from operations -$5.66 -$5.58 -$6.55 -$6.61
Investing activities
Capital expenditures -$0.59 -$0.47 -$2.68 -$0.27
Investments
Total cash flows from investing -$0.59 -$0.47 -$2.68 -$0.27
Financing activities
Dividends paid
Sale and purchase of stock $0.01 -$0.03 -$0.21 $5.85
Net borrowings -$1
Total cash flows from financing $8.52 -$0.03 -$0.21 $4.85
Effect of exchange rate $0.08 $0.31 -$0.15 -$0.22
Change in cash and equivalents $2.35 -$5.78 -$9.59 -$2.26
(in millions $) 31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Net income -$28.63 -$16.16 -$16.83 -$17.86
Operating activities
Depreciation $0.5 $0.4 $0.5 $0.98
Business acquisitions & disposals
Stock-based compensation $2.41 $1.83 $3.37 $2.74
Total cash flows from operations -$26.76 -$16.71 -$12.79 -$12.75
Investing activities
Capital expenditures -$3.73 -$0.71 -$0.1 -$0.21
Investments
Total cash flows from investing -$3.73 -$0.71 -$0.1 -$0.21
Financing activities
Dividends paid
Sale and purchase of stock $5.6 $29.98 $5.68 $9.18
Net borrowings -$1 -$0.03 $2.31 $2.37
Total cash flows from financing $4.6 $29.95 $24.35 $10.72
Effect of exchange rate -$0.11 -$0.24 $0.32 -$0.02
Change in cash and equivalents -$25.99 $12.3 $11.78 -$2.25
Fundamentals
Market cap $2.37M
Enterprise value $11.17M
Shares outstanding 26.33M
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio 0.27
Book/Share 0.33
Cash/Share 0.25
EPS N/A
ROA N/A
ROE N/A
Debt/Equity 6.81
Net debt/EBITDA N/A
Current ratio 1.68
Quick ratio 0.75